Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{172311,
        author = {Dr. Jyotsna Ashokrao Wankhede and Dr. Asha Gangadhar Wankhede and Dr. Monika Pradeep Kaushik and Dr. Subhash N. Uttarwar},
        title = {A Study on China Officinalis and Its Role in Cholelithiasis Management},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {11},
        number = {8},
        pages = {2680-2684},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=172311},
        abstract = {Cholelithiasis, or gallstone disease, is a prevalent condition affecting the biliary system, often leading to abdominal discomfort and complications. Conventional treatments, including surgery, may not always be suitable or preferred. China Officinalis, a homeopathic remedy, has been traditionally used for hepatobiliary disorders, but its role in managing cholelithiasis remains underexplored.  Objective:  To evaluate the therapeutic potential of China Officinalis in the management of cholelithiasis, focusing on symptom relief, gallstone dissolution, and gallbladder function improvement.  Methods: A systematic review of existing literature and experimental studies was conducted to assess the pharmacological properties, mechanisms of action, and clinical outcomes of China Officinalis in cholelithiasis. Observational data from clinical settings were also analysed to provide a comprehensive understanding. Results:  Preliminary findings suggest that China Officinalis exhibits anti-inflammatory and hepatoprotective properties, potentially aiding in symptom relief and supporting gallstone dissolution. Case reports and small-scale studies indicate improved patient outcomes, though robust clinical evidence is limited.  Conclusion:  China Officinalis shows promise as a complementary therapy for cholelithiasis. However, further randomized controlled trials are needed to substantiate its efficacy and establish standardized treatment protocols.},
        keywords = {Cholelithiasis, China Officinalis, gallstones, homeopathy, hepatobiliary disorders},
        month = {January},
        }